​

BioCardia (BCDA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BCDA Stock Rating

BioCardia stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

BCDA Price Target Upside V Benchmarks

TypeNameUpside
StockBioCardia-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.20$2.20$2.20
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-1---1
May, 2511---2
Apr, 2511---2
Mar, 2511---2
Feb, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 14, 2024H.C. WainwrightBuyBuyhold
Nov 11, 2022Dawson JamesNeutraldowngrade

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-22.24$-11.19$-10.08$-8.19-----
Avg Forecast$-24.26$-9.79$-10.00$-5.48$-3.52$-1.22$-1.33$-1.42$-1.03
High Forecast$-24.26$-9.79$-10.00$-4.75$-3.52$-1.22$-1.33$-1.42$-1.03
Low Forecast$-24.26$-9.79$-10.00$-6.09$-3.52$-1.22$-1.33$-1.42$-1.03
Surprise %-8.33%14.30%0.80%49.45%-----

Revenue Forecast

$0 $2M $3M $5M $7M $9M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$145.00K$1.01M$1.35M$477.00K-----
Avg Forecast$268.50K$615.25K$1.27M$700.00K$100.00K$100.00K$100.00K$100.00K$8.40M
High Forecast$268.50K$615.25K$1.27M$700.00K$100.00K$100.00K$100.00K$100.00K$8.40M
Low Forecast$268.50K$615.25K$1.27M$700.00K$100.00K$100.00K$100.00K$100.00K$8.40M
Surprise %-46.00%64.97%6.51%-31.86%-----

Net Income Forecast

$-35M $-28M $-21M $-14M $-7M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-15.01M$-12.62M$-11.91M$-11.57M$-7.95M----
Avg Forecast$-34.26M$-13.82M$-14.12M$-7.66M$-4.97M$-1.72M$-1.88M$-2.01M$-1.45M
High Forecast$-34.26M$-13.82M$-14.12M$-6.71M$-4.97M$-1.72M$-1.88M$-2.01M$-1.45M
Low Forecast$-34.26M$-13.82M$-14.12M$-8.61M$-4.97M$-1.72M$-1.88M$-2.01M$-1.45M
Surprise %-56.20%-8.68%-15.63%51.10%59.87%----

BCDA Forecast FAQ

Is BioCardia stock a buy?

BioCardia stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that BioCardia is a favorable investment for most analysts.

What is BioCardia's price target?

BioCardia's price target, set by 5 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.2.

How does BioCardia stock forecast compare to its benchmarks?

BioCardia's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for BioCardia over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is BioCardia’s EPS forecast?

BioCardia's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.22, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-1.33 in 2026, $-1.42 in 2027, and $-1.03 in 2028.

What is BioCardia’s revenue forecast?

BioCardia's average annual revenue forecast for its fiscal year ending in December 2025 is $100K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $100K, followed by $100K for 2027, and $8.4M for 2028.

What is BioCardia’s net income forecast?

BioCardia's net income forecast for the fiscal year ending in December 2025 stands at $-1.723M, representing a -78.32% decrease from the reported $-7.946M in 2024. Projections indicate $-1.878M in 2026, $-2.005M in 2027, and $-1.454M in 2028.